Improvement of postprandial hyperglycemia in diabetes mellitus.
Improvement of postprandial hyperglycemia in diabetes mellitus. (It should be used only when sufficient effect has not been obtained in patients already undergoing dietary treatment and/or exercise therapy, or when sufficient effect has not been obtained in patients who have been using oral hypoglycemic drugs or insulin preparations, in addition to dietary treatment and/or exercise therapy.)

Voglibose tablets is listed in Drug Catalogs of National Basic Medical Insurance, Industrial Insurance and Birth Insurance (2009 edition), class B.